[Streptokinase and myocardial infarction: can fibrinolysis curb necrosis (author's transl)]. 1977

S Witchitz, and H Kolsky, and P Moisson, and P Chiche

UI MeSH Term Description Entries
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013300 Streptokinase Streptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase (STREPTODORNASE AND STREPTOKINASE). EC 3.4.-. Avelizin,Awelysin,Celiase,Distreptase,Kabikinase,Kabivitrum,Streptase,Streptodecase

Related Publications

S Witchitz, and H Kolsky, and P Moisson, and P Chiche
August 1975, Klinische Wochenschrift,
S Witchitz, and H Kolsky, and P Moisson, and P Chiche
June 1980, Klinische Wochenschrift,
S Witchitz, and H Kolsky, and P Moisson, and P Chiche
August 1988, Archives des maladies du coeur et des vaisseaux,
S Witchitz, and H Kolsky, and P Moisson, and P Chiche
March 2012, JPMA. The Journal of the Pakistan Medical Association,
S Witchitz, and H Kolsky, and P Moisson, and P Chiche
January 1984, Klinicheskaia meditsina,
S Witchitz, and H Kolsky, and P Moisson, and P Chiche
December 1977, Wiener klinische Wochenschrift,
S Witchitz, and H Kolsky, and P Moisson, and P Chiche
February 1980, Deutsche medizinische Wochenschrift (1946),
S Witchitz, and H Kolsky, and P Moisson, and P Chiche
February 1974, Deutsche medizinische Wochenschrift (1946),
S Witchitz, and H Kolsky, and P Moisson, and P Chiche
January 1974, Basic research in cardiology,
S Witchitz, and H Kolsky, and P Moisson, and P Chiche
October 1980, Kokyu to junkan. Respiration & circulation,
Copied contents to your clipboard!